To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...
Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset——Joint poster with Bachem demonstrates ...
Zacks.com on MSN3h
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataAs the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory ...
Researchers from VIB and VUB now provide an interactive tool, based on a single-cell RNA-sequencing (scRNA-seq) atlas of the ...
Tumor/normal exome sequencing and tumor RNA sequencing were used to identify expressed somatic mutations; cancer neoantigens ...
Zymo’s Quick DNA/RNA Viral MagBead Kit was automated using Analytik Jena’s Cybio FeliX pipetting robot. The CyBio FeliX ...
Shares of Avidity Biosciences RNA rose more than 12% on Wednesday after the company announced that it is expanding its ...
Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A ...
At TED AI 2024 in October, one of those eight researchers, Jakob Uszkoreit, spoke with Ars Technica about the development of ...
Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on RNA stock, giving a Buy rating yesterday. Joseph Schwartz has given his Buy rating due to a combination of factors that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback